GlassScriptPhysician profile
Stephen James Meyer
NPI 1255060125
$3,071.61
in general payments reported to CMS, 2019-2025
15 companies · $1,335 in 2025
The $1,335 reported for 2025 was more than what 84% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $937 · 2024: $799 · 2025: $1,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,071.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,324.39 | 2023-2025 | Ortholoc 2 Lapifuse, Augment Injectable, Inbone |
| Treace Medical Concepts, INC. | $406.35 | 2023-2025 | Lapiplasty System |
| Depuy Synthes Sales INC. | $323.93 | 2023-2025 | Motoband, Hammerlock, Fibulink |
| Abbvie INC. | $209.48 | 2023-2024 | |
| Prism Medical | $200.66 | 2024-2025 | |
| Smith+Nephew, INC. | $165.38 | 2023-2024 | Healicoil, Oasis, Stravix |
| Kerecis Limited | $114.88 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Djo, LLC | $92.65 | 2023 | Cmf |
| Bioventus LLC | $61.13 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Vertex Pharmaceuticals Incorporated | $60.07 | 2025 | |
| Paratek Pharmaceuticals, INC. | $38.76 | 2024-2025 | Nuzyra |
| Wardlow Enterprises | $32.27 | 2023 | |
| Convatec INC. | $19.72 | 2025 | |
| Paragon 28, INC. | $15.17 | 2025 | Gorilla |
| Orthofix Medical, INC. | $6.77 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.